Latest Advances

  • Condition: Unresectable Liver Metastases
  • Journal: Cancer control : journal of the Moffitt Cancer Center
  • Treatment Used: Percutaneous Hepatic Perfusion
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of percutaneous hepatic perfusion for treating unresectable hepatic metastases.
  • Condition: Choroidal Melanoma in Korea
  • Journal: PloS one
  • Treatment Used: Proton Beam Therapy (PBT)
  • Number of Patients: 40
  • Published —
This study evaluated the ocular effects of proton beam therapy (PBT) for the treatment of patients with choroidal melanoma in Korea.
  • Condition: Vogt-Koyanagi-Harada disease
  • Journal: Immunotherapy
  • Treatment Used: Nivolumab
  • Number of Patients: 1
  • Published —
The study researched a case of Vogt-Koyanagi-Harada disease.
  • Condition: Choroidal Melanoma
  • Journal: Ophthalmology
  • Treatment Used: Enucleation Versus Iodine 125 Brachytherapy
  • Number of Patients: 0
  • Published —
In this study, researchers compared the effectiveness of enucleation versus iodine 125 brachytherapy for the treatment of choroidal melanoma.
  • Condition: Metastatic cutaneous melanoma to the vitreous (eye)
  • Journal: Ophthalmology
  • Treatment Used: Checkpoint inhibition
  • Number of Patients: 11
  • Published —
This study sought to investigate clinical outcomes, treatment plans as well as clinical findings in patients with metastatic cutaneous melanoma to the vitreous (eye).
  • Condition: Rare melanoma subtypes who have progressed on or after ipilimumab treatment
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: Nivolumab
  • Number of Patients: 1008
  • Published —
The study researched the effects of Nivolumab for patients with rare melanoma subtypes who have progressed on or after ipilimumab treatment.
  • Condition: High-risk Ocular Melanoma
  • Journal: Melanoma research
  • Treatment Used: Ranibizumab
  • Number of Patients: 7
  • Published —
In this study, researchers evaluated the outcomes of intravitreal ranibizumab injections for high-risk ocular melanoma.
  • Condition: Radiation Maculopathy
  • Journal: Ophthalmology. Retina
  • Treatment Used: Aflibercept
  • Number of Patients: 40
  • Published —
The study researched the effects of Aflibercept for radiation maculopathy.
  • Condition: Uveal melanoma liver metastasis
  • Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • Treatment Used: Surgery and radiofrequency ablation
  • Number of Patients: 14
  • Published —
The study researched using surgery and radiofrequency ablation (using electricity to heat/damage tissue) for uveal melanoma liver metastasis.
  • Condition: Liver-dominant metastatic uveal melanoma
  • Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
  • Treatment Used: Percutaneous hepatic perfusion
  • Number of Patients: 16
  • Published —
The aim of the study was to determine the effects of percutaneous hepatic perfusion on liver-dominant metastatic uveal melanoma.
  • Condition: Unresectable Liver Metastases from Ocular Melanoma
  • Journal: Cardiovascular and interventional radiology
  • Treatment Used: Percutaneous Hepatic Perfusion with Melphalan (M-PHP)
  • Number of Patients: 35
  • Published —
This study investigated the safety and toxicity of percutaneous hepatic perfusion with melphalan (M-PHP) with the Delcath Systems' second-generation (GEN 2) filter, and compared the outcomes with historical data from studies using the first-generation filter in patients with unresectable liver metastases from ocular melanoma.
  • Condition: Previous Treated Metastatic Melanoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 51
  • Published —
This study assessed avelumab treatment in patients with previously treated metastatic melanoma.
Showing 1-12 of 22